You are here Home Guidance and resources Prescription medicine determinations and designations Find out more about Prescription medicines determination and designation notices Listen Print Share Loading... Use the filters below to narrow your search. Filter results Open all Close all You can narrow down the results using the filters. Type Priority Review (1) (-) Priority Review (1) Orphan drug (31) Orphan drug (31) Priority review (17) Priority review (17) Provisional approval (14) Provisional approval (14) Outcome date 2020 (1) (-) 2020 (1) 2024 (1) 2024 (1) 2023 (1) 2023 (1) 2021 (3) 2021 (3) 2017 (2) 2017 (2) Search Filters applied:Priority Review2020Clear all Search1 result(s) found, displaying 1 to 1 Notice for avelumab (Merck Healthcare Pty Ltd) 24 April 2020 Designation or determination Priority Review
Notice for avelumab (Merck Healthcare Pty Ltd) 24 April 2020 Designation or determination Priority Review